Logo image
Characterization of "Off-Target" Immune Modulation Induced by Live Attenuated Yellow Fever Vaccine
Journal article   Open access   Peer reviewed

Characterization of "Off-Target" Immune Modulation Induced by Live Attenuated Yellow Fever Vaccine

J. Xiang, Q. Chang, J. H. McLinden, N. Bhattarai, J. L. Welch, T. M. Kaufman and Jack T. Stapleton
The Journal of infectious diseases, Vol.229(3), pp.786-794
03/14/2024
DOI: 10.1093/infdis/jiad086
PMCID: PMC10938199
PMID: 36994927
url
https://doi.org/10.1093/infdis/jiad086View
Published (Version of record) Open Access

Abstract

Live attenuated vaccines induce beneficial clinical outcomes, thought to be due to immune modulation. After yellow fever virus vaccination, we observed a reduction in T-cell receptor signaling. This may be a potential "off target" effect that influences clinical outcomes. Background Live attenuated vaccines alter immune functions and are associated with beneficial outcomes. We previously demonstrated that live attenuated yellow fever virus (YFV) vaccine (LA-YF-Vax) dampens T-cell receptor (TCR) signaling in vitro via an RNA-based mechanism. We examined study participants before and after LA-YF-Vax to assess TCR-mediated functions in vivo. Methods Serum samples and peripheral blood mononuclear cells (PBMCs) were obtained before and after LA-YF-Vax (with or without additional vaccines) or quadrivalent influenza vaccine. TCR-mediated activation was determined by interleukin 2 release or phosphorylation of the lymphocyte-specific Src kinase. TCR-regulating phosphatase (protein tyrosine phosphatase receptor type E [PTPRE]) expression was also measured. Results Compared with prevaccination findings, LA-YF-Vax recipient PBMCs demonstrated transient reduction in interleukin 2 release after TCR stimulation and PTPRE levels, unlike in control participants who received quadrivalent influenza vaccine. YFV was detected in 8 of 14 participants after LA-YF-Vax. After incubation of healthy donor PBMCs in serum-derived extracellular vesicles prepared from LA-YF-Vax recipients, TCR signaling and PTPRE levels were reduced after vaccination, even in participants without detectable YFV RNA. Conclusions LA-YF-Vax reduces TCR functions and PTPRE levels after vaccination. Extracellular vesicles from serum recapitulated this effect in healthy cells. This likely contributes to the reduced immunogenicity for heterologous vaccines after LA-YF-Vax administration. Identification of specific immune mechanisms related to vaccines should contribute to understanding of the "off-target," beneficial effects of live vaccines.
live attenuated yellow fever vaccine T-cell receptor T lymphocyte vaccine Off-target vaccine effects yellow fever virus PTPRE

Details

Metrics

Logo image